Trends in overall mortality among US veterans with primary myelofibrosis

BACKGROUND: Primary myelofibrosis [PMF] is a myeloproliferative neoplasm associated with reduced overall survival (OS). Management strategies for PMF have evolved over the last two decades, including approval of ruxolitinib as the first Janus kinase 1 (JAK1)/JAK2 inhibitor for patients with intermed...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashi, Tsewang, Yu, Jingbo, Pandya, Shivani, Dieyi, Christopher, Scherber, Robyn, Parasuraman, Shreekant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840363/
https://www.ncbi.nlm.nih.gov/pubmed/36641455
http://dx.doi.org/10.1186/s12885-022-10495-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840363/
https://www.ncbi.nlm.nih.gov/pubmed/36641455
http://dx.doi.org/10.1186/s12885-022-10495-6

Ejemplares similares